AOD-9604 vs Tesamorelin.
AOD-9604 vs Tesamorelin: comparing mechanisms, efficacy, dosing and side effects for visceral fat loss and body composition research.
Quick Verdict
Tesamorelin drives stronger fat loss via GH receptor activation (FDA-approved for lipodystrophy). AOD-9604 offers targeted lipolysis without GH receptor binding — ideal for subjects who need fat loss without GH-axis concerns.
Side-by-Side Analysis
| Dimension | AOD-9604 | Tesamorelin |
|---|---|---|
| Mechanism | Mimics GH fat-burning domain. | Stimulates GH for fat metabolism. |
| Primary Benefits | Fat loss without GH side effects | Visceral fat reduction, body recomposition |
| Typical Dose | 300–300mcg | 1000–1000mcg |
| Route | SubQ | SubQ |
| Frequency | 7x/wk | 7x/week |
| Half-Life | 1 hours | 0.43 hours |
| FDA Status | Research Only | Approved |
| Evidence Grade | preclinical | very-strong |
| Key Studies | 18+ indexed | 20+ indexed |
| Lowest Price | $49.99 / 5mg via Amino Club | $69.99 / 10mg via Amino Club |
Which one should you choose?
Who Should Choose AOD-9604?
Choose AOD-9604 if you:
- Want direct lipolysis without GH receptor stimulation
- Are sensitive to blood sugar disruption from GH elevation
- Are researching fat loss as an add-on to an existing GH protocol
- Need a very mild, well-tolerated fat loss agent
Who Should Choose Tesamorelin?
Choose Tesamorelin if you:
- Want the most aggressive visceral fat reduction available
- Are comfortable with the full GHRH mechanism and GH stimulation
- Are researching lipodystrophy or metabolic syndrome specifically
- Want an FDA-approved mechanism with clinical trial data
Can you stack AOD-9604 + Tesamorelin?
These can be stacked carefully. AOD-9604 acts peripherally on fat cells; Tesamorelin acts centrally via the pituitary. The combination may produce additive fat loss effects. However, researchers should monitor IGF-1 and blood glucose when stacking any GH-axis peptide.
Vendor Pricing
· Affiliate links · Prices verified 2026AOD-9604
2 vendorsAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
No — this is AOD-9604's key advantage. It does not bind the GH receptor and does not raise IGF-1 or affect blood sugar, unlike full-length GH or GHRH analogs like Tesamorelin.